Back to top

Image: Bigstock

Here's Why Investors Should Retain BXP Stock in Their Portfolio Now

Read MoreHide Full Article

Key Takeaways

  • BXP's premier office portfolio in select markets is generating rents as return-to-office trends drive demand.
  • Long-term Starr lease was signed at 343 Madison Ave; In Q3 2025, BXP executed 79 leases for 1.5M sq ft.
  • BXP's $3.9B development pipeline and $861.1M cash provide flexibility, though competition remains a concern.

BXP, Inc.’s (BXP - Free Report) assets in a few select markets, well-diversified tenant base, strategic expansions, prudent capital-management practices and solid balance sheet position bode well for long-term growth.

However, high competition from developers, owners and operators of office properties remains a concern for BXP. Huge development pipeline exposes the company to the risk of rising construction costs.

What’s Supporting BXP?

BXP's portfolio of premier office assets, concentrated in a few select high-rent, high-barrier-to-entry geographic markets and a solid tenant base, enables it to generate stable rental revenues, even during periods of economic downturn. The return-to-office policies implemented by many companies are likely to drive the demand for BXP's strategically located, high-quality office properties.

In January 2026, BXP announced that Starr had signed a long-term lease at 343 Madison Avenue, which is currently under development near Grand Central. In the third quarter of 2025, the company executed 79 leases totaling around 1.5 million square feet with a weighted average lease term of 7.9 years. This emphasizes the sustained demand and long-term commitment by corporates for quality office spaces with premier amenities as their key business strategy.

Its long-term leases with tenants having a solid credit profile assure stable cash flows. The office REIT’s tenant roster includes several industry bellwethers, such as Salesforce, Biogen, Google, Bank of America, Microsoft and Wellington Management. Moreover, amid strong demand from life-science tenants, the company is converting numerous straight office buildings to laboratory/life science spaces in its suburban portfolio.

BXP has been focusing on successfully executing its capital reallocation strategy. The company is boosting its portfolio quality through repositioning initiatives like acquisitions and the development of properties in core markets and shedding properties in non-core markets. Such moves highlight the company’s prudent capital management practices and relieve the pressure on its balance sheet.

Moreover, the company has an encouraging development and redevelopment pipeline, which bodes well for its long-term growth. As of Sept. 30, 2025, BXP has eight properties under its development and redevelopment pipeline, with its share of estimated total investment aggregating around $3.9 billion.

BXP has a healthy balance sheet position with ample liquidity. The company exited the third quarter of 2025 with cash and cash equivalents of $861.1 million. Given its solid financial position, BXP seems well-poised to navigate any economic uncertainty and industry choppiness and capitalize on growth opportunities.

What's Hurting BXP?

Competition from developers, owners and operators of office properties, of companies such as SL Green (SLG - Free Report) and Vornado (VNO - Free Report) and other commercial real estate, affects BXP’s ability to retain tenants at relatively higher rents and curbs its pricing power. Given this backdrop, it will be challenging for the company to face SLG and VNO and more, to backfill tenant move-outs and vacancies in the near term.

Although a huge development pipeline is encouraging for long-term growth, it exposes the company to the risk of rising construction costs and lease-up concerns.


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


BXP, Inc. (BXP) - free report >>

Vornado Realty Trust (VNO) - free report >>

SL Green Realty Corporation (SLG) - free report >>

Published in